Kezar Life Sciences, Inc. (KZR)
7.34
-0.02
(-0.27%)
USD |
NASDAQ |
May 08, 12:13
Kezar Life Sciences Market Cap : 54.11M for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Apellis Pharmaceuticals, Inc. | 5.245B |
| ACADIA Pharmaceuticals, Inc. | 3.845B |
| Alnylam Pharmaceuticals, Inc. | 39.57B |
| Savara, Inc. | 1.048B |
| BioMarin Pharmaceutical, Inc. | 10.45B |
Market Cap Related Metrics
| Price to Book Value | 0.7722 |
| Price | 7.34 |
| Earnings Yield | -104.3% |